Does Mounjaro wear off towards the end of the week?

Tirzepatide has a half-life of approximately five days, so levels decline gradually over the week rather than falling off a cliff.
Mild hunger returning late in the week is common and does not mean your dose is insufficient — it reflects the natural pharmacokinetic curve.
Persistent or disruptive end-of-week symptoms are worth raising with your prescriber at your next clinical review, not managing alone.
Dose changes must be assessed clinically, never adjust timing or amount without your prescriber's guidance and the Patient Information Leaflet.

Mounjaro (tirzepatide) stays active in your body for the full seven days between injections — it does not simply wear off on day six or seven. Its half-life of roughly five days means blood levels taper gradually rather than dropping sharply, so the medicine is still working on injection day, even if some people notice their appetite returning slightly in the final day or two. That gradual decline is a feature of the pharmacokinetics, not a sign the medicine has stopped working. Because these are prescription-only medicines that require a full clinical assessment before you can start, a prescriber will account for how your body responds when reviewing your dose.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What is actually happening during those last 24–48 hours, and when does it matter?

Why do some people feel hungrier on day six or seven?

Tirzepatide works as a dual GIP and GLP-1 receptor agonist, slowing gastric emptying and reducing appetite through two complementary pathways. After you inject, blood concentrations peak within roughly 24–72 hours and then decline steadily. By day seven they have fallen to their lowest point of the weekly cycle before the next injection restores them.

For most people this taper is barely noticeable. Appetite suppression does not switch off like a light; it dims very slowly. A subset of people, though, find they are slightly more aware of hunger in the final 24–48 hours, or that their appetite returns more noticeably towards the end of the week, and if that sounds familiar you may find it helpful to read more about whether Mounjaro wears off towards the end of the week. That experience is real, but it is worth understanding what is driving it before assuming something has gone wrong.

The tirzepatide page has a fuller explanation of how the dual-agonist mechanism works throughout the dosing cycle. The NHS medicines information for tirzepatide, available on the NHS website, also covers what to expect between doses and when to seek advice.

Does end-of-week fading mean the dose needs to go up?

Not necessarily, and this is where people sometimes make an unhelpful leap. Mild end-of-week hunger is a normal feature of weekly dosing for many patients, particularly in the earlier months of treatment. It does not automatically signal that your current dose is failing or that you need to escalate sooner than your prescriber planned.

Dose titration with Mounjaro follows a careful schedule, typically moving in four-week steps, and for good reason: moving up too quickly increases the likelihood of nausea and other gastrointestinal side effects. The starting dose is calibrated to settle your system, with therapeutic effect building over the full titration programme. Jumping ahead because of a few hungry Fridays can cost you elsewhere.

If the end-of-week pattern is genuinely disruptive (you are eating in ways that feel hard to control, or the difference between early-week and late-week is stark enough to be affecting your day) that is a conversation for your prescriber, not a reason to self-adjust. Our clinical team at nume reviews every repeat order before it is dispensed, which means there is a natural checkpoint to raise exactly this kind of question.

Can you shift your injection day to even things out?

Some patients wonder whether moving their weekly injection day (say, from Monday to Thursday) might smooth out the taper. In principle, adjusting your injection day is possible, but it should only be done with your prescriber's guidance and after consulting the Patient Information Leaflet; the timing rules matter, and the transition period needs to be handled carefully.

It is also worth pausing before attributing all late-week hunger to the medicine. Stress, poor sleep, under-eating earlier in the week (a common pattern on tirzepatide, where appetite suppression early in the week can lead to very low calorie intake) and hydration all influence how hungry you feel. If your weekly injection happens to land on a Monday and payday or a busy weekend falls on day six, the context around appetite matters as much as the pharmacokinetics, and our page looking at how Mounjaro wears off as the week goes on unpacks those pharmacokinetic details clearly.

If you are considering a change to your injection schedule, the page on when Mounjaro wears off covers the timing questions in more detail, and the FAQs address several common scheduling queries.

When should you actually be concerned?

End-of-week appetite returning slightly is expected. There are other signals that do warrant prompt attention, and it is useful to know the difference.

Speak to your prescriber or GP (or call 111 if it is urgent) if you experience severe or persistent stomach pain, especially if it radiates to your back, with or without vomiting. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines; the Yellow Card scheme is also there for reporting any suspected side effects you think others should know about.

More broadly, if you are wondering whether Mounjaro wears off by the end of the week or if your overall response feels weaker than it did in earlier months (not just on day seven, but throughout the week) or if weight loss has stalled for a sustained period, that is worth a proper clinical review rather than self-diagnosis. Our prescribers look at the whole picture when a repeat order comes in, including whether the current dose and schedule still make sense for you. You can explore treatment options and start a free consultation if you have not yet begun, or raise questions through the aftercare contact page if you are already a patient.

For a wider look at how Mounjaro fits into a structured weight management plan, the weight loss overview is a practical starting point, and the Mounjaro pillar page brings together the clinical background in one place.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions